The European Medicines Agency (EMA) wants to slash agricultural use of colistin, a last-ditch antibiotic in treatment of infection and disease in humans, by two-thirds, said Reuters. The regulatory agency issued its call at the same time the MCR-1 gene, which enables bacteria to resist colistin, was identified for the first time in the United… » Read More
The Ag Insider content is only available to members.